In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.
Introduction A disproportionate share of global neonatal deaths occurs in armed-conflict settings, where progress in reducing neonatal mortality remains slow. This systematic review aims to synthesise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results